C2Caveat is an interactive drug design tool that can increase productivity by suggesting interesting new synthetic targets de novo. Through C2
Caveat's unique vector pair searching capabilities, all possible skeletons upon which drug candidates can be constructed can be easily identified. These new skeletons can then be optimized using the QSAR tools available in Cerius2.
Jo Ellen Collins
Dir., Inside Sales/Mar Com
BIOSYM Technologies Inc
16 New England Executive Park
Burlington, MA 01803
USA
617-229-9800
617-229-9899 (fax)
jcollins@msi.com
For applications in related solution areas, see the following indices: Bioengineering, Computational Chemistry, DNA Sequencing, Molecular Biology, Molecular Modeling, the developer index for BIOSYM Technologies Inc and the market segment index for Chemistry, Biochem, Biotech, Materials.